Literature DB >> 31844011

Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant Aspergillus Section Fumigati Clinical Isolates.

S Dellière1, L Verdurme1, J Bigot1, E Dannaoui2,3, Y Senghor1, F Botterel3,4, A Fekkar5, M E Bougnoux6, C Hennequin7, J Guitard1.   

Abstract

Reference methods used to assess the drug susceptibilities of Aspergillus fumigatus isolates consisted of EUCAST and CLSI standardized broth microdilution techniques. Considering the increasing rate and the potential impact on the clinical outcome of azole resistance in A. fumigatus, more suitable techniques for routine testing are needed. The gradient concentration strip (GCS) method has been favorably evaluated for yeast testing. The aim of this study was to compare the CGS test with EUCAST broth microdilution for amphotericin B (AMB), posaconazole (PCZ), itraconazole (ITZ), voriconazole (VRZ), and isavuconazole (ISA). A total of 121 Aspergillus section Fumigati strains were collected, including 24 A. fumigatus sensu stricto strains that were resistant to at least one azole drug. MICs were determined using GCS and EUCAST methods. Essential agreement between the 2 methods was considered when MICs fell within ±1 dilution or ±2 dilutions of the 2-fold dilution scale. Categorical agreement was defined as the percentage of strains classified in the same category (susceptible, intermediate, or resistant) with both methods. Essential agreements with ±1 dilution and ±2 dilutions were 96.7, 93.4, 90.0, 89.3, and 95% and 100, 99.2, 100, 97.5, and 100% for AMB, PCZ, ITZ, VRZ, and ISA, respectively. Categorical agreements were 94.3, 86.1, 89.3, and 88.5% for AMB, PCZ, ITZ, and VRZ, respectively. Detection of resistance was missed with the GCS for one strain (4.1%) for PCZ and for 2 strains (8.3%) for ISA. Determination of ITZ MICs using the GCS allowed the detection of 91.7% of azole-resistant strains. The GCS test appears to be a valuable method for screening azole-resistant A. fumigatus clinical isolates.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus fumigatus; CYP51A; EUCAST; antifungal susceptibility testing; azole resistance; gradient concentration strip

Mesh:

Substances:

Year:  2020        PMID: 31844011      PMCID: PMC7038237          DOI: 10.1128/AAC.01597-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

Authors:  M C Arendrup; J Meletiadis; J W Mouton; J Guinea; M Cuenca-Estrella; K Lagrou; S J Howard
Journal:  Clin Microbiol Infect       Date:  2016-02-03       Impact factor: 8.067

2.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

Review 3.  In vitro susceptibility testing in Aspergillus species: an update.

Authors:  Cornelia Lass-Flörl
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

4.  Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.

Authors:  Evgeny A Idelevich; Uwe Groß; Karsten Becker; Oliver Bader
Journal:  Diagn Microbiol Infect Dis       Date:  2018-01-09       Impact factor: 2.803

5.  Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

Authors:  David W Denning; Jacques Cadranel; Catherine Beigelman-Aubry; Florence Ader; Arunaloke Chakrabarti; Stijn Blot; Andrew J Ullmann; George Dimopoulos; Christoph Lange
Journal:  Eur Respir J       Date:  2016-01       Impact factor: 16.671

6.  Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Authors:  A Espinel-Ingroff; J Turnidge; A Alastruey-Izquierdo; F Botterel; E Canton; C Castro; Y-C Chen; Y Chen; E Chryssanthou; E Dannaoui; G Garcia-Effron; G M Gonzalez; N P Govender; J Guinea; S Kidd; M Lackner; C Lass-Flörl; M J Linares-Sicilia; L López-Soria; R Magobo; T Pelaez; G Quindós; M A Rodriguez-Iglesia; M A Ruiz; F Sánchez-Reus; M Sanguinetti; R Shields; P Szweda; A Tortorano; N L Wengenack; S Bramati; C Cavanna; C DeLuca; M Gelmi; A Grancini; G Lombardi; J Meletiadis; C E Negri; M Passera; J Peman; A Prigitano; E Sala; M Tejada
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

7.  Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.

Authors:  M A Pfaller; S A Messer; A Bolmström
Journal:  Diagn Microbiol Infect Dis       Date:  1998-11       Impact factor: 2.803

Review 8.  European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Authors:  Johan A Maertens; Corrado Girmenia; Roger J Brüggemann; Rafael F Duarte; Christopher C Kibbler; Per Ljungman; Zdenek Racil; Patricia Ribaud; Monica A Slavin; Oliver A Cornely; J Peter Donnelly; Catherine Cordonnier
Journal:  J Antimicrob Chemother       Date:  2018-12-01       Impact factor: 5.790

9.  Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.

Authors:  Pieter P Lestrade; Robbert G Bentvelsen; Alexander F A D Schauwvlieghe; Steven Schalekamp; Walter J F M van der Velden; Ed J Kuiper; Judith van Paassen; Ben van der Hoven; Henrich A van der Lee; Willem J G Melchers; Anton F de Haan; Hans L van der Hoeven; Bart J A Rijnders; Martha T van der Beek; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

10.  Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing.

Authors:  Simone M T Camps; Bas E Dutilh; Maiken C Arendrup; Antonius J M M Rijs; Eveline Snelders; Martijn A Huynen; Paul E Verweij; Willem J G Melchers
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more
  2 in total

1.  Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Cryptic Isolates from Aspergillus Section Fumigati.

Authors:  S Imbert; A C Normand; S Cassaing; F Gabriel; L Kristensen; C Bonnal; L Lachaud; D Costa; J Guitard; L Hasseine; M Palous; M Piarroux; M Hendrickx; R Piarroux; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

2.  Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU - A case report.

Authors:  Théo Ghelfenstein-Ferreira; Anastasia Saade; Alexandre Alanio; Stéphane Bretagne; Raffael Araujo de Castro; Samia Hamane; Elie Azoulay; Swann Bredin; Sarah Dellière
Journal:  Med Mycol Case Rep       Date:  2020-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.